These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18978296)

  • 1. AB0-incompatible allogeneic hematopoietic stem cell transplantation.
    Worel N; Kalhs P
    Haematologica; 2008 Nov; 93(11):1605-7. PubMed ID: 18978296
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
    Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
    Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.
    Stussi G; Halter J; Schanz U; Seebach JD
    Transfus Apher Sci; 2006 Aug; 35(1):59-69. PubMed ID: 16935028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation from a major ABO-incompatible donor. Infusion of hemopoietic stem cells isolated by Ficoll-Hypaque method.
    Harada M; Aoyagi N; Kondo K; Ishino C; Odaka K; Matsue K; Yoshida T; Hattori K
    Transplantation; 1983 Feb; 35(2):191-2. PubMed ID: 6131551
    [No Abstract]   [Full Text] [Related]  

  • 7. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility].
    Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation.
    Franchini M; Gandini G; Aprili G
    Bone Marrow Transplant; 2004 Jun; 33(12):1169-72. PubMed ID: 15094753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
    Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
    Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation.
    Oziel-Taieb S; Faucher-Barbey C; Chabannon C; Ladaique P; Saux P; Gouin F; Gastaut JA; Maraninchi D; Blaise D
    Bone Marrow Transplant; 1997 Jun; 19(11):1155-6. PubMed ID: 9193761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation.
    Goldman J; Liesveld J; Nichols D; Heal J; Blumberg N
    Leuk Res; 2003 Jun; 27(6):489-91. PubMed ID: 12648507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
    Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
    Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T; Sun J; Liu J; Liu QF; Men FY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohematologic issues in ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Akkök ÇA; Seghatchian J
    Transfus Apher Sci; 2018 Dec; 57(6):812-815. PubMed ID: 30404742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Techniques for bone marrow preparation--a comparison of various systems].
    Zingsem J; Weisbach V; Zeiler T; Heuft HG; Siegert W; Eckstein R
    Beitr Infusionsther; 1990; 26():208-10. PubMed ID: 1703832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs.
    Rowley SD
    Bone Marrow Transplant; 2001 Aug; 28(4):315-21. PubMed ID: 11571501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
    Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fischer GF; Faé I; Kalhs P; Pohlreich D; Kouba M; Dobrovolna M; Greinix HT
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1400-6. PubMed ID: 19822299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do I approach ABO-incompatible hematopoietic progenitor cell transplantation?
    Daniel-Johnson J; Schwartz J
    Transfusion; 2011 Jun; 51(6):1143-9. PubMed ID: 21382041
    [No Abstract]   [Full Text] [Related]  

  • 19. ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.
    Mielcarek M; Torok-Storb B; Storb R
    Bone Marrow Transplant; 2002 Oct; 30(8):547-8; author reply 548. PubMed ID: 12379898
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation with major ABO blood group incompatibility using automated removal of red blood cells from incompatible bone marrow by CS 3000 plus.
    O-Charoen R; Soiprasert P; Chaisiripoomkere W; Jootar S; Chiewsilp P
    Transplant Proc; 1994 Aug; 26(4):2352-3. PubMed ID: 8066772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.